Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Treasury Shares (2018 - 2025)

Viemed Healthcare's Treasury Shares history spans 8 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 40.95% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $2.1 million, up 40.95%, while the annual FY2025 figure was $2.1 million, 40.95% up from the prior year.
  • Treasury Shares reached $2.1 million in Q4 2025 per VMD's latest filing, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.2 million in Q1 2025 to a low of $323053.0 in Q3 2022.
  • Average Treasury Shares over 5 years is $1.2 million, with a median of $1.1 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: plummeted 59.0% in 2022, then soared 265.72% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $573000.0 in 2021, then increased by 9.77% to $629000.0 in 2022, then soared by 94.91% to $1.2 million in 2023, then grew by 23.49% to $1.5 million in 2024, then skyrocketed by 40.95% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Treasury Shares are $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $2.2 million (Q2 2025).